Rare diseases
Investigational molecules
Locations
343 Oyster Point Boulevard Suite 120, 94080-1913, United States
Research activity is centered on Parkinson’s disease, with attention to both early Parkinson disease and idiopathic Parkinson disease. The sponsor’s clinical interest extends across Parkinson and parkinsonism-related disease presentations, reflecting a focused neurology portfolio.
The trial landscape indicates a specific therapeutic emphasis on disease-modifying approaches for movement disorders associated with Parkinsonian syndromes.
Neuron23 Inc. runs clinical trials in conditions such as Parkinson's disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
